Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
3.200
+0.040 (1.27%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $76.18 million as of September 18, 2026. Its market cap has decreased by -8.26% in one year.
Market Cap
76.18M
Enterprise Value
-15.96M
1-Year Change
-8.26%
Ranking
Category
Stock Price
$3.20
ChartMarket Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $76.18M, a decrease of -64.49%. That is a compound annual growth rate of -49.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 76.18M | -51.74% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 81.64M |
| NeOnc Technologies Holdings | 81.03M |
| Connect Biopharma Holdings | 80.61M |
| MAIA Biotechnology | 79.68M |
| Acrivon Therapeutics | 79.28M |
| Gain Therapeutics | 76.81M |
| Verrica Pharmaceuticals | 76.45M |
| RenovoRx | 76.27M |